SCHEMBL3760239

SCHEMBL3760239

Oc1cccc(O)c1C1(c2c(O)cccc2O)C2CC3CC(C2)CC1C3

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 8/20 0.37
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
HSD17B10 Q99714 3/20 0.35
KDM4E B2RXH2 2/20 0.35
MAPT P10636 2/20 0.35
TSHR P16473 1/20 0.35
ALOX12 P18054 1/20 0.35
HTT P42858 1/20 0.35
ATM Q13315 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
EGFR P00533 2/20 0.35
CA2 P00918 2/20 0.35
LMNA P02545 2/20 0.35
FYN P06241 2/20 0.35
MMP9 P14780 2/20 0.35
ALOX15 P16050 2/20 0.35
RECQL P46063 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
ADAMTS4 O75173 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3757397 0.83 MEN1 (0.35) HSD11B1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL3762633 0.81 MEN1 (0.32) HSD11B1MEN1KMT2AGAAPOLB
SCHEMBL3765893 0.80 ALDH1A1 (0.39) HSD11B1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL3132046 0.79 ALOX5AP (0.40) HSD11B1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL3976170 0.72 ALOX5AP (0.41) HSD11B1ALDH1A1HSD17B10CA2LMNA
SCHEMBL3752942 0.71 MEN1 (0.52) ALDH1A1HPGDHSD17B10KDM4EMAPT
SCHEMBL10296820 0.70 IDO1 (0.45) HSD11B1MEN1KMT2AGAAPOLB
SCHEMBL4585681 0.70
SCHEMBL175542 0.70 HSD11B1 (0.41) HSD11B1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL3754199 0.69 MEN1 (0.59) HSD11B1MEN1KMT2AGAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8084650-B2 Adamantane derivative, resin composition containing same, and optoelectronic member and sealing agent for electronic circuit using those IDEMITSU KOSAN CO., LTD. (JP) 2011-12-27 US disclosed
US-20100298491-A1 ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC MEMBER AND SEALING AGENT FOR ELECTRONIC CIRCUIT USING THOSE IDEMITSU KOSAN CO., LTD. (JP) 2010-11-25 US disclosed
EP-1985616-A1 ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC MEMBER AND SEALING AGENT FOR ELECTRONIC CIRCUIT USING THOSE Idemitsu Kosan Co., Ltd. (JP) 2008-10-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298491-A1 ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC MEMBER AND SEALING AGENT FOR ELECTRONIC CIRCUIT USING THOSE AOC1, ASIC1, ICAM1 HSD11B1 4146/4885ALDH1A1 10/4885HPGD 1071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.